Harmony Biosciences Holdings, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
HRMY on Nasdaq
Industry
Pharmaceutical Preparations
Location
630 W Germantown Pike, Suite 215, Plymouth Meeting, PA

Insiders trading volume in the past year

Harmony Biosciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marshman Fund Trust II 10%+ Owner $183M -$139M -43.2% Nov 1, 2024
Andreas Wicki Director $71.7M Dec 12, 2022
Jeffrey S. Aronin Director $8.4M Mar 24, 2022
Jeffrey M. Dayno PRESIDENT, CEO, Director $2.2M -$774K -26% Jan 24, 2025
Sandip Kapadia Chief Financial Officer $1.08M -$2.09M -66% Sep 30, 2025
Adam H. Zaeske Chief Commercial Officer $993K Apr 7, 2025
Valor IV Pharma Holdings, LLC 10%+ Owner $866K -$139M -99.4% Aug 28, 2025
Kumar Budur Chief Medical Officer $700K May 1, 2025
Jeffrey Dierks Chief Commercial Officer $512K -$3.38M -86.9% Mar 3, 2025
Andrew Serafin Chief Strategy Officer $480K Jan 24, 2025
Juan A. Sabater Director May 15, 2025
Eric Motley Director May 20, 2021
Jack Nielsen Director May 29, 2024
Gary Sender Director May 15, 2025
Linda M. Szyper Director May 15, 2025
John C. Jacobs PRESIDENT, CEO, Director Aug 15, 2022
R. Mark Graf Director May 15, 2025
Peter Anastasiou Director May 15, 2025
Antonio J. Gracias Director May 15, 2025
Ron M. Philip Director May 15, 2025

Recent Insider Transactions by Companies or Individuals for Harmony Biosciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.